COMMUNIQUÉ DE PRESSE publié le 10/09/2026 à 15:48, il y a 17 heures 25 minutes Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses 5.49% ownership of LondonMetric Property plc and 0.95% ownership of Schroder Real Estate Investment Trust Limited. Details in Form 8.3 LondonMetric Property Plc Form 8.3 The Vanguard Group Ownership Disclosure Schroder Real Estate Investment Trust Limited
COMMUNIQUÉ DE PRESSE publié le 10/09/2026 à 15:47, il y a 17 heures 26 minutes Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses 2.98% interest in Picton Property Income Limited. Details of securities transactions provided. Disclosure made under the Code Securities Transactions Disclosure The Vanguard Group Picton Property Income Limited
COMMUNIQUÉ DE PRESSE publié le 10/09/2026 à 15:46, il y a 17 heures 27 minutes Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc. The Vanguard Group, Inc. discloses a 13.53% ownership in Prologis, Inc. and dealings in relevant securities. Additional disclosures for SEGRO plc Disclosure The Vanguard Group Dealings Ownership Prologis Inc.
COMMUNIQUÉ DE PRESSE publié le 10/09/2026 à 15:45, il y a 17 heures 28 minutes Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses a 2.72% interest in Schroders plc's 20p ordinary securities, with details of recent dealings revealed. Form 8.3 submission on 10-Sep-2026 Securities The Vanguard Group, Inc. Form 8.3 Disclosure Schroders Plc
COMMUNIQUÉ DE PRESSE publié le 10/09/2026 à 15:43, il y a 17 heures 30 minutes Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses 5.68% ownership in SEGRO plc through Form 8.3 filing. Prologis, Inc. also involved in disclosures The Vanguard Group, Inc. Form 8.3 Ownership Disclosure SEGRO PLC Prologis, Inc.
BRÈVE publiée le 09/09/2026 à 16:10, il y a 1 jour 17 heures Le groupe Vanguard révèle sa participation dans Tate & Lyle Code De Prise De Contrôle Investissement Institutionnel Le Groupe Vanguard Déclaration Des Participations Tate & Lyle
BRÈVE publiée le 09/09/2026 à 16:10, il y a 1 jour 17 heures The Vanguard Group Discloses Stake in Tate & Lyle The Vanguard Group Takeover Code Stake Disclosure Institutional Investment Tate & Lyle
BRÈVE publiée le 09/09/2026 à 16:09, il y a 1 jour 17 heures Le groupe Vanguard révèle sa participation dans Spire Healthcare Group. Spire Healthcare Groupe Vanguard Formulaire 8.3 Informations Sur Les Investissements Position Boursière
BRÈVE publiée le 09/09/2026 à 16:09, il y a 1 jour 17 heures The Vanguard Group Discloses Position in Spire Healthcare Group Form 8.3 Vanguard Group Spire Healthcare Investment Disclosure Stock Position
BRÈVE publiée le 09/09/2026 à 16:08, il y a 1 jour 17 heures Le groupe Vanguard révèle sa participation dans SEGRO plc Code De Prise De Contrôle Le Groupe Vanguard Formulaire 8.3 SEGRO PLC Information Sur Les Investissements
Publié le 11/09/2026 à 07:00, il y a 2 heures 14 minutes Transparantiekennisgeving van Baltisse Groep
Publié le 11/09/2026 à 07:00, il y a 2 heures 14 minutes BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Publié le 11/09/2026 à 07:00, il y a 2 heures 14 minutes BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Publié le 10/09/2026 à 19:30, il y a 13 heures 44 minutes Availability of the 2026 Interim Financial Report
Publié le 11/09/2026 à 04:00, il y a 5 heures 14 minutes Torq Announces Debt Settlement and Corporate Update
Publié le 10/09/2026 à 22:25, il y a 10 heures 49 minutes Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Publié le 10/09/2026 à 15:20, il y a 17 heures 54 minutes MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Publié le 10/09/2026 à 15:00, il y a 18 heures 14 minutes All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Publié le 11/09/2026 à 09:05, il y a 8 minutes ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Publié le 11/09/2026 à 09:00, il y a 14 minutes Homann Holzwerkstoffe publishes its 2026 half-year report
Publié le 11/09/2026 à 09:00, il y a 14 minutes Mountain Alliance AG invests in Evolved Aerospace and expands its involvement in the European defence technology market
